Business, energy, technology, markets and global industry news from Business News Today

Stanford Medicine

PharmaDeviceNews Stanford Medicine
Representative image: Upright radiotherapy and imaging setup highlighting Leo Cancer Care’s $65 million Series D push to scale seated cancer treatment, proton therapy access and oncology device deployment.
Medical Devices & Diagnostics

Leo Cancer Care targets proton therapy access with $65m Series D financing

Leo Cancer Care has raised $65 million in Series D financing to scale its integrated upright cancer care platform, which is designed to image and treat patients in a seated position rather than the conventional lying-down setup. The oversubscribed round supports manufacturing scale-up, commercial deployment and continued development across upright proton therapy, photon therapy and

Read More
Representative image of pulmonary fibrosis drug discovery research, as Simcere Pharmaceutical Group Limited and Stanford Medicine collaborate on early-stage therapies for idiopathic pulmonary fibrosis.
Pharma & Biotech

Could Simcere’s Stanford Medicine IPF deal expose the next big gap in fibrosis treatment?

Find out how Simcere and Stanford Medicine’s IPF collaboration could reshape early-stage antifibrotic drug discovery.

Read More
Mevion’s S250-FIT arrives in Europe with a sharper pitch for proton therapy access
Medical Devices & Diagnostics

Can Mevion’s S250-FIT make proton therapy practical for more cancer centers?

Proton therapy has long had an infrastructure problem. Mevion’s S250-FIT asks whether existing LINAC vaults can change that.

Read More